Insulin antibody as a biomarker to monitor the development of type 2 diabetes in county hospitals in China.
| Publicado en: | International Journal of Diabetes in Developing Countries Vol. 43; no. 3; pp. 435 - 441 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Jun2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163850290&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 163850290 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09733930 259E jtl: International Journal of Diabetes in Developing Countries issn: 09733930 maglogo: N pubinfo: dt: Jun2023 vid: 43 iid: 3 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 163850290 158204032 163850290 163850290 10.1007/s13410-022-01110-2 163850290 ppf: 435 ppct: 6 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Insulin antibody as a biomarker to monitor the development of type 2 diabetes in county hospitals in China. aug: au: Yao, Dan Zhu, Ziqing Chen, Zhiyan Qiu, Jianda Feng, Caiyun Zhu, Xianzhi Zhou, Qianyun Chu, Jianping affil: Department of Endocrinology, Xiangshan Hospital of TCM Medical and Health Group, Xiangshan, Ningbo, China sug: subj: Diabetes Mellitus, Type 2 Drug Therapy Insulin Therapeutic Use Antibodies Blood Biological Markers Blood Insulin Immunology Drug Efficacy Human Male Female Middle Age Aged China Descriptive Statistics Blood Glucose C-Peptide Blood Insulin Blood Insulin Administration and Dosage Funding Source Middle Aged: 45-64 years Aged: 65+ years Male Female pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|